Latest Breaking News On - Prnewswire maxcyte inc - Page 1 : comparemela.com

MaxCyte Signs Strategic Platform License with Catamaran Bio to Support its CAR-NK Cell Therapy Programs

MaxCyte's Flow Electroporation® and ExPERT technologies to be used to enhance Catamaran's TAILWIND® platform for novel CAR-NK cell therapies ROCKVILLE, Md, Jan. 3, 2023 /PRNewswire/

Doug doerflerPrnewswire maxcyte incLinkedinSv health investorsCatamaran bio incTwitterNasdaqFlow electroporationCatamaran bioSofinnova partnersLightstone venturesTakeda venturesAstellas venture managementMaxcyteSignsStrategic

MaxCyte Reports Third Quarter 2022 Financial Results

22% Year-Over-Year Core Business Revenue Growth in Third Quarter 2022 Reiterates 2022 Revenue Guidance ROCKVILLE, Md., Nov. 9, 2022 /PRNewswire/ MaxCyte, Inc., (NASDAQ: MXCT; LSE:

Doug doerflerExchange commissionMaxcyte incPrnewswire maxcyte incExchange commission onNasdaqYear over core business revenue growthThird quarterConference callFlow electroporationPrivate securities litigation reform actAnnual reportConsolidated statementsMonths ended septemberNet lossMaxcyte

MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md., Aug. 10, 2022 /PRNewswire/

United kingdomChris welshDavid deuchlerMary jane elliottDoug doerflerEmma earl freddy crossleyPanmure gordonRupert deardenExchange commissionMaxcyte incPrnewswire maxcyte incExchange commission onGilmartin groupNasdaqConsilium strategic communicationsYear over core business revenue growth

MaxCyte Reports Fourth Quarter and Full Year Financial Results

GAITHERSBURG, Md., March 22, 2022 /PRNewswire/ MaxCyte, Inc., (NASDAQ: MXCT) (LSE: MXCT) is a leading commercial cell-engineering company focused on providing enabling platform technologies

Doug doerflerJim allisonMaxcyte incPrnewswire maxcyte incExchange commission onSana biotechnology incCancer research instituteMyeloid therapeutics incNasdaqExchange commissionCelularity incNkarta incStanford universityIntima bioscienceMyeloid therapeuticsSana biotechnology

MaxCyte, Inc.: MaxCyte announces filing of Form 10-Q for the quarterly period ended June 30, 2021

MaxCyte, Inc.: MaxCyte announces filing of Form 10-Q for the quarterly period ended June 30, 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

DelawareUnited statesGaithersburgMarylandUnited kingdomWashingtonAmericaBritishDavid deuchlerDoug doerflerDouglas doerflerAmanda murphyChris welshMary jane elliottPanmure gordonEmma earl freddy crossley